The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    Song Joong-ki marries British woman, expects baby

  • 3

    Suicidal pedestrian saved over Han River bridge

  • 5

    US four-star general warns of war with China in 2025

  • 7

    Korean Lunar New Year vs. Chinese Lunar New Year

  • 9

    Over 76% of South Koreans support development of nuclear weapons

  • 11

    INTERVIEWBusan has potential to be world-class city, says mayor

  • 13

    Koreans reluctant to unmask on first day of eased indoor mask rule

  • 15

    Samsung to introduce low-carbon diet for employees to help tackle climate change

  • 17

    Base taxi fare to rise by 1,000 won to 4,800 won next month

  • 19

    Stock-leveraged investments rise again amid bullish KOSPI

  • 2

    Japanese teen romance film attracts 1 mil. Korean viewers for 1st time in 21 yrs

  • 4

    Korea to lift indoor mask mandate Monday

  • 6

    Kim Jung-hyun returns to small screen with 'Kokdu: Season of Deity'

  • 8

    K-pop releases for February

  • 10

    Youth, foreign drug offenders increase threefold in 5 years

  • 12

    'Someday or One Day' cast says film spin-off has new plot

  • 14

    NK rejects alleged arms trading with Russia, warns of 'undesirable result'

  • 16

    Seoul International School celebrates 50th anniversary

  • 18

    Plum trees, pheasants and promises of old Korea

  • 20

    Main opposition leader faces pressure to resign in case of indictment

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Tue, January 31, 2023 | 22:54
Health & Science
Remdesivir becomes available to COVID-19 patients
Posted : 2020-07-01 19:51
Updated : 2020-07-01 19:54
Kim Se-jeong
Print PreviewPrint Preview
Font Size UpFont Size Up
Font Size DownFont Size Down
  • facebook
  • twitter
  • kakaolink
  • whatsapp
  • reddit
  • mailto
  • link
Remdesivir became available for COVID-19 treatment in Korea, Wednesday. Yonhap
Remdesivir became available for COVID-19 treatment in Korea, Wednesday. Yonhap

By Kim Se-jeong

The government made an Ebola drug, remdesivir, available for limited use in the treatment of COVID-19 patients with serious symptoms, Wednesday, in a move to treat the infectious disease.

The government announced 33 patients would be in the first group to receive the drug treatment, adding the prescription will be allowed only for those with pneumonia and in need of oxygen treatment.

The National Medical Center which is responsible for distributing the drug for the entire country will collect and review the prescription requests before releasing the drug, which was developed by U.S. biopharmaceutical company Gilead Sciences Inc.

The government said it has enough in stock to treat patients until the end of July, but from August it will have to negotiate again with the company.

The treatment will be free of charge in July. In the U.S., the drug is sold for $3,120 per 100 mg, equivalent to 3.75 million won.

Remdesivir was found to have shortened the recovery period among patients with serious symptoms by 31 percent in a recent clinical trial undertaken in the U.S. The drug can be administered for up to 10 days in a row.

S. Korea administers remdesivir for COVID-19 patients for 1st time
S. Korea administers remdesivir for COVID-19 patients for 1st time
2020-07-02 16:05  |  Health & Science

Medical experts believe the remdesivir treatment will help to free up hospital beds and other resources available in healthcare facilities.

"The government will continue to work with Gilead Sciences Korea to get additional supplies," Jung Eun-kyeong, director of the Korea Centers for Disease Control and Prevention, said during a daily press briefing, Wednesday.

However, experts said there is still a long way to go until the infectious disease is under control. Vaccine development is critical and is estimated to take at least one year.

According to the KCDC, Korea reported 51 new cases on Tuesday, bringing the total number of cases to 12,850. The death toll remained at 282.

Among 51 new cases, 36 were local infections linked to infection clusters, while the rest involved people who recently traveled abroad.

Two among the 36 were elementary school students from Daejeon who are believed to have contracted the virus from their peers or teachers at school, raising concerns about the school's preventive measures against COVID-19.

"We've seen cases involving students and teachers but they mostly contracted the virus through family members. We haven't seen children or teachers contracting the virus from others at school. We're looking closely into how the transmission happened," Jung said.

Meanwhile, almost 80,000 entertainment facilities, such as clubs, bars and karaoke rooms across the country, became obliged to scan the personal QR codes of all visitors, Wednesday, with sanctions to be applied to businesses found to be in violation.

The QR-based entry log system was put into place last month, but violators weren't sanctioned until the end of June. Fines will be up to 3 million, together with a business shutdown.

Remdesivir became available for COVID-19 treatment in Korea, Wednesday. Yonhap
Workers at the Gayang Elementary School in Daejeon hang a shutdown notice at the school's door, Wednesday, after two COVID-19 cases were confirmed. Yonhap

Emailskim@koreatimes.co.kr Article ListMore articles by this reporter
 
Top 10 Stories
1Korean Lunar New Year vs. Chinese Lunar New Year Korean Lunar New Year vs. Chinese Lunar New Year
2Over 76% of South Koreans support development of nuclear weapons Over 76% of South Koreans support development of nuclear weapons
3Koreans reluctant to unmask on first day of eased indoor mask rule Koreans reluctant to unmask on first day of eased indoor mask rule
4Stock-leveraged investments rise again amid bullish KOSPI Stock-leveraged investments rise again amid bullish KOSPI
5[ANALYSIS] Pandemic awakens demand for data-driven automation ANALYSISPandemic awakens demand for data-driven automation
6SPC opens 120th Paris Baguette store in US SPC opens 120th Paris Baguette store in US
7Busan seeks to take lead in expo race after BIE's April visit Busan seeks to take lead in expo race after BIE's April visit
8Retailers seek to bolster beauty product sales as lifting of mask mandate approaches Retailers seek to bolster beauty product sales as lifting of mask mandate approaches
9Biohealth geared for growth Biohealth geared for growth
10NK slams NATO chief's Seoul visit as 'prelude to war' NK slams NATO chief's Seoul visit as 'prelude to war'
Top 5 Entertainment News
1Song Joong-ki marries British woman, expects baby Song Joong-ki marries British woman, expects baby
2Kim Jung-hyun returns to small screen with 'Kokdu: Season of Deity' Kim Jung-hyun returns to small screen with 'Kokdu: Season of Deity'
3K-pop releases for February K-pop releases for February
4'Someday or One Day' cast says film spin-off has new plot 'Someday or One Day' cast says film spin-off has new plot
5Itaewon music fest brings love to the healing process Itaewon music fest brings love to the healing process
DARKROOM
  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

  • World Cup 2022 France vs Morocco

    World Cup 2022 France vs Morocco

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group